Drug shortages

Lisdexamfetamine Dimesylate Capsule

Apotex Corp. · Available

Current60505-4743-1Psychiatry
Open FDA's page for this record
Update type
Reverified
Initial posting date
11/01/2023
Package NDC
60505-4743-1
Generic name
Lisdexamfetamine Dimesylate Capsule
Contact info
800-706-5575
Availability
Available
Update date
11/17/2026
Dosage form
Capsule
Presentation
Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 60505-4743-1)
Company name
Apotex Corp.
Status
Current
Therapeutic category
Psychiatry
Harmonized identifiers (openFDA)
Application number
ANDA216944
Brand name
LISDEXAMFETAMINE DIMESYLATE
Generic name
LISDEXAMFETAMINE DIMESYLATE
Manufacturer name
Apotex Corp.
Product NDC
60505-4743, 60505-4739, 60505-4740, 60505-4741, 60505-4742, 60505-4744, 60505-4745
Product type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Substance name
LISDEXAMFETAMINE DIMESYLATE
RxCUI
854830, 854834, 854838, 854842, 854846, 854850, 1593856
SPL ID
0190bec9-05e4-0977-9548-2cc150b53e74
SPL set ID
ecad4442-a644-18e3-6ff2-fdbac45eec47
Package NDC
60505-4739-1, 60505-4740-1, 60505-4741-1, 60505-4742-1, 60505-4743-1, 60505-4744-1, 60505-4745-1
UNII
SJT761GEGS
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.